Kannel WB, McGee DL: Diabetes and cardiovascular diseases. The Framingham Study. JAMA. 1979, 241: 2035-2038. 10.1001/jama.241.19.2035.
Article
CAS
PubMed
Google Scholar
Grundy SM, Howard B, Smith S Jr, Eckel R, Redberg R, Bonow RO: Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation. 2002, 105: 2231-2239. 10.1161/01.CIR.0000013952.86046.DD.
Article
PubMed
Google Scholar
Kempler P: Learning from large cardiovascular clinical trials: classical cardiovascular risk factors. Diabetes Res Clin Pract. 2005, 68: S43-S47. 10.1016/j.diabres.2005.03.005.
Article
PubMed
Google Scholar
Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes. other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993, 16: 434-44. 10.2337/diacare.16.2.434.
Article
CAS
PubMed
Google Scholar
Lowe LP, Liu K, Greenland P, Metzger BE, Dyer AR, Stamler J: Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men: the Chicago Heart Association Detection Project in Industry study. Diabetes Care. 1997, 20: 163-169. 10.2337/diacare.20.2.163.
Article
CAS
PubMed
Google Scholar
Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willett WC, Manson JE: Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care. 2002, 25: 1129-1134. 10.2337/diacare.25.7.1129.
Article
PubMed
Google Scholar
Fonseca V, Desouza C, Asnani S, Jialal I: Nontraditional risk factors for cardiovascular disease in diabetes. Endocr Rev. 2004, 25: 153-175. 10.1210/er.2002-0034.
Article
CAS
PubMed
Google Scholar
Hershko A, Ciechanover A, Varshavsky A: Basic medical research award. The ubiquitin system. Nat Med. 2002, 6: 1073-1081. 10.1038/80384.
Article
Google Scholar
Herrmann J, Ciechanover A, Lerman LO, Lerman A: The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extended. Cardiovasc Res. 2004, 61: 11-21. 10.1016/j.cardiores.2003.09.033.
Article
CAS
PubMed
Google Scholar
Ciechanover A, Hod Y, Hershko A: A heat-stable polypeptide component of an ATP-dependent proteolytic system from reticulocytes. Biochem Biophys Res Commun. 1978, 81: 1100-1105. 10.1016/0006-291X(78)91249-4.
Article
Google Scholar
Mitch WE, Goldberg AL: Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med. 1996, 335: 1897-1905. 10.1056/NEJM199612193352507.
Article
CAS
PubMed
Google Scholar
Arrigo AP, Tanaka K, Goldberg AL, Welch WJ: Identity of the 19S 'prosome' particle with the large multifunctional protease complex of mammalian cells the proteasome. Nature. 1998, 331: 192-194. 10.1038/331192a0.
Article
Google Scholar
Hicke L, Schubert HL, Hill CP: Ubiquitin-binding domains. Nat Rev Mol Cell Biol. 2005, 6: 610-621. 10.1038/nrm1701.
Article
CAS
PubMed
Google Scholar
Goldberg AL: Protein degradation and protection against misfolded or damaged proteins. Nature. 2003, 426: 895-899. 10.1038/nature02263.
Article
CAS
PubMed
Google Scholar
Palombella VJ, Rando J, Goldberg A, Maniatis T: The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell. 1994, 78: 773-785. 10.1016/S0092-8674(94)90482-0.
Article
CAS
PubMed
Google Scholar
Wilson SH, Caplice NM, Simari RD, Holmes DR, Carlson PJ, Lerman A: Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemia. Atherosclerosis. 2000, 148: 23-30. 10.1016/S0021-9150(99)00211-7.
Article
CAS
PubMed
Google Scholar
Collins T, Cybulsky MI: NF-kappaB. pivotal mediator or innocent bystander in atherogenesis?. J Clin Invest. 2001, 107: 255-264.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ishii T, Itoh K, Sato H, Bannai S: Oxidative stress-inducible proteins in macrophages. Free Radic Res. 1999, 31: 351-355. 10.1080/10715769900300921.
Article
CAS
PubMed
Google Scholar
Kikuchi J, Furukawa Y, Kubo N: Induction of ubiquitin-conjugating enzyme by aggregated low density lipoprotein in human macrophages and its implications for atherosclerosis. Arterioscler Thromb Vasc Biol. 2000, 20: 128-134.
Article
CAS
PubMed
Google Scholar
Versari D, Herrmann J, Gössl M, Mannheim D, Sattler K, Meyer FB, Lerman LO, Lerman A: Dysregulation of the ubiquitin-proteasome system in human carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 2006, 26: 2132-2139. 10.1161/01.ATV.0000232501.08576.73.
Article
CAS
PubMed
Google Scholar
Marfella R, D'Amico M, Di Filippo C, Baldi A, Siniscalchi M, Sasso FC, Portoghese M, Carbonara O, Crescenzi B, Sangiuolo P, Nicoletti GF, Rossiello R, Cacciapuoti F, Verza M, Coppola L, Rossi F, Paolisso G: Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment. J Am Coll Cardiol. 2006, 47: 2444-2455. 10.1016/j.jacc.2006.01.073.
Article
CAS
PubMed
Google Scholar
Siebenlist U, Franzoso G, Brown K: Structure. regulation and function of NF-kappa B. Annu Rev Cell Biol. 1994, 10: 405-455. 10.1146/annurev.cb.10.110194.002201.
Article
CAS
PubMed
Google Scholar
Herrmann J, Gulati R, Napoli C, Woodrum JE, Lerman LO, Rodriguez-Porcel M: Oxidative stress-related increase in ubiquitination in early coronary atherosclerosis. FASEB J. 2003, 17: 1730-1732.
CAS
Google Scholar
Nigro J, Osman N, Dart AM, Little PJ: Insulin Resistance and Atherosclerosis. Endocrine Reviews. 2006, 27: 242-259. 10.1210/er.2005-0007.
Article
CAS
PubMed
Google Scholar
Zeng G, Nystrom FH, Ravichandran LV, Cong LN, Kirby M, Mostowski H, Quon MJ: Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation. 2000, 101: 1539-1545.
Article
CAS
PubMed
Google Scholar
Komalavilas P, Shah PK, Jo H, Lincoln TM: Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells. J Biol Chem. 1999, 274: 34301-3439. 10.1074/jbc.274.48.34301.
Article
CAS
PubMed
Google Scholar
Wang X, Hu Z, Hu J, Du J, Mitch WE: Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signalling. Endocrinology. 2006, 147: 4160-4168. 10.1210/en.2006-0251.
Article
CAS
PubMed
Google Scholar
Balasubramanyam M, Sampathkumar R, Mohan V: Is insulin signaling molecules misguided in diabetes for ubiquitin-proteasome mediated degradation?. Mol Cell Biochem. 2005, 275: 117-1125. 10.1007/s11010-005-1083-y.
Article
CAS
PubMed
Google Scholar
Pallares-Trujillo J, Carbo N, Lopez-Soriano FJ, Argiles JM: Does the mechanism responsible for TNF-mediated insulin resistance involve the proteasome?. Med Hypotheses. 2000, 54: 565-569. 10.1054/mehy.1999.0895.
Article
CAS
PubMed
Google Scholar
Medina EA, Afsari RR, Ravid T, Castillo SS, Erickson KL, Goldkorn T: Tumor necrosis factor-{alpha} decreases Akt protein levels in 3T3-L1 adipocytes via the caspase-dependent ubiquitination of Akt. Endocrinology. 2006, 146: 2726-2735. 10.1210/en.2004-1074.
Article
Google Scholar
Fujita T, Doihara H, Washio K, Kawasaki K, Takabatake D, Takahashi H, Tsukuda K, Ogasawara Y, Shimizu N: Proteasome inhibitor bortezomib increases PTEN expression and enhances trastuzumab-induced growth inhibition in trastuzumab-resistant cells. Anticancer Drugs. 2006, 17: 455-462. 10.1097/01.cad.0000198910.90819.06.
Article
CAS
PubMed
Google Scholar
Del Prato S: Loss of early insulin secretion leads to postprandial hyperglycaemia. Diabetologia. 2003, 46: M2-M8.
CAS
PubMed
Google Scholar
Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med. 1999, 340: 115-126. 10.1056/NEJM199901143400207.
Article
CAS
PubMed
Google Scholar
Libby P: Inflammation in atherosclerosis. Nature. 2002, 420: 868-874. 10.1038/nature01323.
Article
CAS
PubMed
Google Scholar
Ceriello A: Postprandial hyperglycemia and diabetes complications is it time to treat?. Diabetes. 2005, 54: 1-7. 10.2337/diabetes.54.1.1.
Article
CAS
PubMed
Google Scholar
Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R, Nappo F, Lucarelli C, D'Onofrio F: Vascular effects of acute hyperglycemia in humans are reversed by L-arginine: evidence for reduced availability of nitric oxide during hyperglycemia. Circulation. 1997, 95: 1783-1790.
Article
CAS
PubMed
Google Scholar
Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature. 2000, 414: 813-820. 10.1038/414813a.
Article
Google Scholar
Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T: Upregulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett. 2005, 360: 291-293. 10.1016/0014-5793(95)00124-R.
Article
Google Scholar
Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 2005, 271: C1424-C1437.
Google Scholar
Marfella R, Quagliaro L, Nappo F, Ceriello A, Giugliano D: Acute hyperglycemia induces an oxidative stress in healthy subjects. J Clin Invest. 2001, 108: 635-636. 10.1172/JCI0113727A.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ceriello A, Quagliaro L, D'Amico M, Di Filippo C, Marfella R, Nappo F, Berrino L, Rossi F, Giugliano D: Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes. 2002, 51: 1076-1082. 10.2337/diabetes.51.4.1076.
Article
CAS
PubMed
Google Scholar
Xu J, Wu Y, Song P, Zhang M, Wang S, Zou MH: Proteasome-dependent degradation of guanosine 5'-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus. Circulation. 2007, 116: 944-953. 10.1161/CIRCULATIONAHA.106.684795.
Article
CAS
PubMed
Google Scholar
Wei Q, Xia Y: Proteasome inhibition down-regulates endothelial nitric-oxide synthase phosphorylation and function. J Biol Chem. 2006, 281: 21652-21659. 10.1074/jbc.M602105200.
Article
CAS
PubMed
Google Scholar
Kone BC, Kuncewicz T, Zhang W, Yu ZY: Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide. Am J Physiol Renal Physiol. 2003, 285: F178-F190.
Article
CAS
PubMed
Google Scholar
Stangl V, Lorenz M, Meiners S, Ludwig A, Bartsch C, Moobed M: Long-term up-regulation of eNOS and improvement of endothelial function by inhibition of the ubiquitin-proteasome pathway. FASEB. 2004, 18: 272-279. 10.1096/fj.03-0054com.
Article
CAS
Google Scholar
Govers R, de Bree P, Rabelink TJ: Involvement of the proteasome in activation of endothelial nitric oxide synthase. Life Sci. 2003, 73: 2225-2236. 10.1016/S0024-3205(03)00644-1.
Article
CAS
PubMed
Google Scholar
Cai D, Frantz JD, Tawa NE, Melendez PA, Oh BC. Lidov HG: IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell. 2004, 119: 2852-2898. 10.1016/j.cell.2004.09.027.
Article
Google Scholar
Marfella R, D'Amico M, Esposito K, Baldi A, Di Filippo C, Siniscalchi M, Sasso FC, Portoghese M, Cirillo F, Cacciapuoti F, Carbonara O, Crescenzi B, Baldi F, Ceriello A, Nicoletti GF, D'Andrea F, Verza M, Coppola L, Rossi F, Giugliano D: The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment. Diabetes. 2006, 55: 622-632. 10.2337/diabetes.55.03.06.db05-0832.
Article
CAS
PubMed
Google Scholar
Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002, 106: 2067-2072. 10.1161/01.CIR.0000034509.14906.AE.
Article
CAS
PubMed
Google Scholar
Nappo F, Esposito K, Cioffi M, Giugliano G, Molinari AM, Paolisso G, Marfella R, Giugliano D: Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol. 2002, 139: 1145-1150. 10.1016/S0735-1097(02)01741-2.
Article
Google Scholar
Katagiri K, Yokosawa H, Kinashi T, Kawashima S, Irie S, Tanaka K, Katagiri T: Ubiquitin-proteasome system is involved in induction of LFA-1/ICAM-1-dependent adhesion of HL-60 cells. J Leukoc Biol. 1996, 65: 778-785.
Google Scholar
Lopes-Virella MF, Virella G: Immune mechanism of atherosclerosis in diabetes mellitus. Diabetes. 1992, 41: 86-91. 10.2337/diabetes.41.5.610.
Article
PubMed
Google Scholar
Cominacini L, Fratta Pasini A, Garbin U, Davoli A, De Santis A, Campagnola M, Rigoni A, Zenti MG, Moghetti P, Lo Cascio V: Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia. 1995, 38: 1122-1124. 10.1007/BF00402185.
Article
CAS
PubMed
Google Scholar
Ceriello A, Falleti E, Bortolotti N, Motz E, Cavarape A, Russo A, Gonano F, Bartoli E: Increased circulating ICAM-1 levels in type-2 diabetic patients: the possible role of metabolic control and oxidative stress. Metabolism. 1996, 45: 498-501. 10.1016/S0026-0495(96)90226-7.
Article
CAS
PubMed
Google Scholar
Marfella R, Esposito K, Giunta R, Coppola G, De Angelis L, Farzati B, Paolisso G, Giugliano D: Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation. 2000, 101: 2247-2251.
Article
CAS
PubMed
Google Scholar
Krunkosky TM, Martin LD, Fischer BM, Voynow JA, Adler KB: Effects of TNFalpha on expression of ICAM-1 in human airway epithelial cells in vitro: oxidant-mediated pathways and transcription factors. Free Radic Biol Med. 2003, 35: 1158-1167. 10.1016/S0891-5849(03)00498-2.
Article
CAS
PubMed
Google Scholar
Berti R, Williams AJ, Velarde LC, Moffett JR, Elliott PJ, Adams J, Yao C, Dave JR, Tortella FC: Effect of the proteasome inhibitor MLN519 on the expression of inflammatory molecules following middle cerebral artery occlusion and reperfusion in the rat. Neurotox Res. 2003, 5: 505-514.
Article
CAS
PubMed
Google Scholar
Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998, 339: 229-234. 10.1056/NEJM199807233390404.
Article
CAS
PubMed
Google Scholar
Burke JP, Williams K, Gaskill SP, Hazuda HP, Haffner SM, Stern MP: Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. Arch Intern Med. 1999, 159: 1450-1456. 10.1001/archinte.159.13.1450.
Article
CAS
PubMed
Google Scholar
Gu K, Cowie CC, Harris MI: Diabetes and decline in heart disease mortality in US adults. JAMA. 1999, 281: 1291-1297. 10.1001/jama.281.14.1291.
Article
CAS
PubMed
Google Scholar
Pyörälä K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study 4S. Diabetes Care. 1997, 20: 614-620. 10.2337/diacare.20.4.614.
Article
PubMed
Google Scholar
Hansson L, Zanchetti A, Carruthers SG: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment HOT randomised trial. Lancet. 1998, 351: 1755-1762. 10.1016/S0140-6736(98)04311-6.
Article
CAS
PubMed
Google Scholar
Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003, 348: 383-393. 10.1056/NEJMoa021778.
Article
PubMed
Google Scholar
Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J: From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation. 2003, 108: 1772-1778. 10.1161/01.CIR.0000087481.55887.C9.
Article
PubMed
Google Scholar
Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation. 2002, 105: 1135-1143. 10.1161/hc0902.104353.
Article
CAS
PubMed
Google Scholar
Eckel RH, Wassef M, Chait A, Sobel B, Barrett E, King G: AHA Conference Proceedings Prevention Conference VI: Diabetes and Cardiovascular Disease Writing Group II: Pathogenesis of atherosclerosis in diabetes. Circulation. 2002, 105: 138-148. 10.1161/01.CIR.0000013954.65303.C5.
Article
Google Scholar
Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J: From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003, 108: 1664-1672. 10.1161/01.CIR.0000087480.94275.97.
Article
PubMed
Google Scholar
Moreno PR, Murcia AM, Palacios IF: Coronary composition and macrophage infiltration in atherectomy specimens from persons with diabetes mellitus. Circulation. 2000, 102: 2180-2184.
Article
CAS
PubMed
Google Scholar
Burke AP, Varghese PJ, Peterson E: Large lipid core and extensive plaque burden are features of coronary atherosclerosis in patients with non-insulin dependent diabetes mellitus. J Am Coll Cardiol. 2001, 37: 257A.
Article
Google Scholar
Marfella R, Di Filippo C, Baldi A, Siniscalchi M, Sasso FC, Crescenzi B, Cirillo F, Nicoletti GF, D'Andrea F, Chiorazzo G, Musacchio E, Rossi F, Verza M, Coppola L, D'Amico M: The vascular smooth muscle cells apoptosis in asymptomatic diabetic carotid plaques: role of glycemic control. J Am Coll Cardiol. 2006, 47: 2118-2120. 10.1016/j.jacc.2006.02.025.
Article
CAS
PubMed
Google Scholar
Van Gaal LF, Mertens IL, De Block CE: Mechanisms linking obesity with cardiovascular disease. Nature. 2006, 444: 875-880. 10.1038/nature05487.
Article
CAS
PubMed
Google Scholar
Roebuck KA: Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB. Int J Mol Med. 1999, 4: 223-230.
CAS
PubMed
Google Scholar
Ceriello A, Motz E: Is oxidative stress the pathogenic mechanism underlying insulin resistance. diabetes. and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol. 2004, 24: 816-823. 10.1161/01.ATV.0000122852.22604.78.
Article
CAS
PubMed
Google Scholar
Schmitz ML, Bacher S, Kracht M: I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations. Trends Biochem Sci. 2001, 26: 186-190. 10.1016/S0968-0004(00)01753-9.
Article
CAS
PubMed
Google Scholar
von der Thusen JH, van Vlijmen BJ, Hoeben RC: Induction of atherosclerotic plaque rupture in apolipoprotein E-/- mice after adenovirus-mediated transfer of p53". Circulation. 2002, 105: 2064-2070. 10.1161/01.CIR.0000015502.97828.93.
Article
PubMed
Google Scholar
Lu Y, Wahl LM: Production of matrix metalloproteinase-9 by activated human monocytes involves a phosphatidylinositol-3 kinase/Akt/IKKalpha/NF-kappaB pathway. J Leukoc Biol. 2005, 78: 259-265. 10.1189/jlb.0904498.
Article
CAS
PubMed
Google Scholar
Schmitz ML, Bacher S, Kracht M: I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations. Trends Biochem Sci. 2001, 26: 186-190. 10.1016/S0968-0004(00)01753-9.
Article
CAS
PubMed
Google Scholar
Adams J, Palombella VJ, Elliott PJ: Proteasome inhibition: a new strategy in cancer treatment. Invest New Drugs. 2000, 18: 109-121. 10.1023/A:1006321828515.
Article
CAS
PubMed
Google Scholar
Barbier O, Torra IP, Duguay Y: Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol. 2002, 22: 717-726. 10.1161/01.ATV.0000015598.86369.04.
Article
CAS
PubMed
Google Scholar
Huang YC, Chuang LY, Hung WC: Mechanisms underlying nonsteroidal anti-inflammatory drug-induced p27Kip1 expression. Mol Pharmacol. 2002, 62: 1515-1521. 10.1124/mol.62.6.1515.
Article
CAS
PubMed
Google Scholar